Zydus Wellness

Why is Zydus Wellness Ltd falling/rising?

As of 23-Jun, Zydus Wellness Ltd's stock is experiencing a short-term decline of 1.42% after two days of gains, but it has a strong long-term performance with a year-to-date increase of 15.98%. Despite the current drop, investor interest remains high, as indicated by a significant rise in delivery volume.

As of 23-Jun, Zydus Wellness Ltd's stock price is currently falling, with a change of -7.6, representing a decrease of 1.42%. This decline follows a trend reversal after two consecutive days of gains. Additionally, the stock has underperformed its sector by 0.86% today and touched an intraday low of Rs 524.7, which is a decrease of 2.29%. <BR><BR>Despite these short-term declines, Zydus Wellness has shown strong performance over longer periods, with a year-to-date increase of 15.98% and a one-year return of 29.40%. The stock is also trading above its moving averages, indicating a generally positive trend over time. Furthermore, there has been a significant increase in investor participation, with delivery volume rising by 424.88% against the five-day average, suggesting continued interest in the stock despite the current price drop. <BR><BR>Overall, while the stock is experiencing a decline in the short term, its long-term performance remains strong, and the fundamentals indicate a solid position for the company.

Which are the latest news on Zydus Wellness?

How big is Zydus Wellness?

As of 10th June, Zydus Wellness Ltd has a market capitalization of 16,169.00 Cr, with net sales of 3,961.00 Cr and a net profit of 197.20 Cr reported in the latest four quarters.

As of 10th June, Zydus Wellness Ltd has a market capitalization of 16,169.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Zydus Wellness reported Net Sales of 3,961.00 Cr and a Net Profit of 197.20 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 5,671.60 Cr and Total Assets of 6,297.20 Cr.

Who are in the management team of Zydus Wellness?

The management team of Zydus Wellness includes key members such as Tarun Arora (CEO), Sharvil P Patel (Chairman), and several non-executive and independent directors, overseeing the company's operations and strategic direction.

The management team of Zydus Wellness includes the following key members:<BR><BR>1. **Ganesh N Nayak** - Non-Executive & Non-Independent Director<BR>2. **Sharvil P Patel** - Chairman (Non-Executive)<BR>3. **Tarun Arora** - Whole Time Director & CEO<BR>4. **Kulin S Lalbhai** - Non-Executive & Independent Director<BR>5. **Ashish Bhargava** - Nominee<BR>6. **Dharmishta N Rawal** - Non-Executive & Independent Director<BR>7. **Srivishnu Raju Nandyala** - Non-Executive & Independent Director<BR>8. **Nandish P. Joshi** - Company Secretary & Compliance Officer<BR>9. **Akhil A. Monappa** - Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Who are the peers of the Zydus Wellness?

Zydus Wellness's peers include Gillette India, Cupid, Hatsun Agro, Emami, Bikaji Foods, CCL Products, Avanti Feeds, Honasa Consumer, Godrej Agrovet, and The Bombay Burma. In terms of performance, Zydus Wellness has a 1-year return of 25.81%, with average management risk and excellent capital structure compared to its peers.

Peers: The peers of Zydus Wellness are Gillette India, Cupid, Hatsun Agro, Emami, Bikaji Foods, CCL Products, Avanti Feeds, Honasa Consumer, Godrej Agrovet, and The Bombay Burma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Gillette India, Emami, and the rest. Average management risk is found at Cupid, Zydus Wellness, Honasa Consumer, and the rest. Good management risk is noted at Hatsun Agro, Bikaji Foods, CCL Products, Avanti Feeds, Godrej Agrovet, and the rest. Below Average growth is seen in Gillette India, Hatsun Agro, Emami, Zydus Wellness, and the rest, while Good growth is noted at Cupid, Honasa Consumer, and the rest. Average growth is found at Bikaji Foods, CCL Products, and the rest, with Below Average growth at Avanti Feeds, Godrej Agrovet, and the rest. Excellent capital structure is observed at Gillette India, Emami, Zydus Wellness, and the rest, while Average capital structure is noted at Hatsun Agro, CCL Products, Godrej Agrovet, and the rest.<BR><BR>Return Snapshot: Cupid has the highest 1-year return at 698.82%, while Emami has the lowest at -34.18%. Zydus Wellness's 1-year return of 25.81% is significantly higher than Emami's but lower than Cupid's. Additionally, the peers with negative six-month returns include Hatsun Agro, Emami, Bikaji Foods, and Godrej Agrovet.

What does Zydus Wellness do?

Zydus Wellness Ltd is a small-cap FMCG company specializing in health and wellness products, with net sales of ₹1,485 Cr and a net profit of ₹162 Cr as of March 2026. The company was incorporated in 1994 and has undergone several name changes, with its latest name change occurring in 2009.

Overview: <BR>Zydus Wellness Ltd operates in the FMCG industry and is categorized as a small-cap company.<BR><BR>History: <BR>Zydus Wellness Limited was incorporated on November 1, 1994, originally as 'Carnation Health Foods Limited'. The company underwent several name changes, with the latest being on January 5, 2009, when it became Zydus Wellness Limited. The most recent quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>- Net Sales: 1,485 Cr (Quarterly Results - Mar 2026) <BR>- Net Profit: 162 Cr (Quarterly Results - Mar 2026) <BR>- Market Cap: INR 16,169 Cr (Small Cap) <BR><BR>Key Metrics: <BR>- P/E: 67.00 <BR>- Industry P/E: 45 <BR>- Dividend Yield: 0.24% <BR>- Debt Equity: 0.53 <BR>- Return on Equity: 4.09% <BR>- Price to Book: 2.78 <BR><BR>Contact Details: <BR>Address: Zydus Corporate Park S No 536, Sarkhej-Gandhinagar Highway Ahmedabad Gujarat : 382481 <BR>Tel: 91-79-67775888 <BR>Email: investor.grievance@zyduswellness.in <BR>Website: http://www.zyduswellness.in

Are Zydus Wellness Ltd latest results good or bad?

Zydus Wellness Ltd's latest results show strong revenue growth with net sales up 62.60% year-on-year, but profitability is a concern as net profit declined by 5.76% and operating margins fell. Investors should be cautious due to rising costs and low return on equity despite the impressive sales figures.

Zydus Wellness Ltd's latest results present a mixed picture. On one hand, the company achieved impressive revenue growth, with net sales soaring to ₹1,484.70 crores in Q4 FY26, reflecting a remarkable 62.60% increase year-on-year and a 53.87% rise from the previous quarter. This marks the highest quarterly revenue in the company's history, indicating strong demand for its wellness products.<BR><BR>However, the profitability aspect raises some concerns. While net profit rebounded to ₹162.00 crores, this represents a 5.76% decline compared to the same quarter last year. Additionally, the operating margin decreased to 18.30%, down from 20.87% a year earlier, which suggests rising costs or pricing pressures that have affected profitability despite the significant revenue growth.<BR><BR>The substantial increase in interest expenses, which nearly doubled year-on-year, further complicates the financial outlook. The company's return on equity (ROE) remains low at 5.92%, indicating challenges in generating adequate returns for shareholders.<BR><BR>In summary, while Zydus Wellness has demonstrated strong revenue growth, the decline in profitability and rising costs suggest that the company faces operational challenges that need to be addressed. Investors may want to approach the stock with caution, considering both the positive revenue momentum and the concerning profitability trends.

Should I buy, sell or hold Zydus Wellness Ltd?

When is the next results date for Zydus Wellness Ltd?

The next results date for Zydus Wellness Ltd is 18 May 2026.

The next results date for Zydus Wellness Ltd is scheduled for 18 May 2026.

Is Zydus Wellness overvalued or undervalued?

As of November 6, 2025, Zydus Wellness is considered overvalued with a valuation grade of expensive, reflected by a PE ratio of 49.20 and a recent 1-week decline of 8.76%, despite a strong year-to-date return of 14.50%.

As of 6 November 2025, the valuation grade for Zydus Wellness has moved from fair to expensive, indicating a shift in its market perception. The company is currently considered overvalued. Key ratios include a PE ratio of 49.20, an EV to EBITDA of 44.54, and a Price to Book Value of 0.25, which suggest that the stock is trading at a premium compared to its earnings and asset value.<BR><BR>In comparison to its peers, Zydus Wellness has a lower PE ratio than Hindustan Unilever, which stands at 54.11, and Nestle India, which has a PE of 81.85. However, the overall valuation of Zydus Wellness remains expensive in the context of the FMCG sector, where many peers are also categorized as very expensive. Despite a strong year-to-date return of 14.50% compared to the Sensex's 6.62%, the stock's recent performance has been lackluster, with a 1-week decline of 8.76%, reinforcing the notion that it may be overvalued at current levels.

How has been the historical performance of Zydus Wellness?

Zydus Wellness has shown consistent growth in net sales and profits from March 2020 to March 2025, with net sales increasing from 1,766.82 Cr to 2,708.90 Cr and operating profit peaking at 393.30 Cr, despite some fluctuations in profit margins and cash flow. Total liabilities rose to 6,297.20 Cr, while cash flow from operations improved to 380.00 Cr.

Answer:<BR>The historical performance of Zydus Wellness shows a consistent growth trajectory in net sales and profit over the years, with notable fluctuations in profit margins and cash flow.<BR><BR>Breakdown:<BR>Zydus Wellness has demonstrated significant growth in net sales, increasing from 1,766.82 Cr in March 2020 to 2,708.90 Cr in March 2025. The total operating income has mirrored this growth, reaching 2,708.90 Cr in March 2025, up from 1,766.82 Cr in March 2020. The operating profit (PBDIT) has also shown an upward trend, with a peak of 393.30 Cr in March 2025, although it experienced some fluctuations in previous years. Profit before tax reached 358.80 Cr in March 2025, while profit after tax stood at 346.90 Cr, indicating a healthy profitability despite a slight decline from the previous year. The company’s total liabilities increased to 6,297.20 Cr in March 2025, up from 5,468.89 Cr in March 2020, reflecting a rise in both short-term and long-term borrowings. Cash flow from operating activities improved significantly to 380.00 Cr in March 2025, compared to 259.00 Cr in March 2020, although the net cash outflow was recorded at -13.00 Cr in March 2025. Overall, Zydus Wellness has shown resilience and growth in its financial performance over the years.

Is Zydus Wellness technically bullish or bearish?

As of November 3, 2025, the trend is mildly bullish with daily moving averages supporting this view, but mixed signals from the MACD and KST suggest a cautious approach.

As of 3 November 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by the daily moving averages indicating bullish momentum. The weekly MACD is mildly bearish, while the monthly MACD remains bullish, suggesting mixed signals across time frames. Bollinger Bands are bullish on both weekly and monthly charts, reinforcing the positive outlook. However, the KST shows a bullish weekly trend but is mildly bearish monthly, indicating some caution. Overall, while there are bullish indicators, the mixed signals suggest a cautious approach.

Who are the top shareholders of the Zydus Wellness?

The top shareholders of Zydus Wellness include Zydus Lifesciences Limited with 57.59%, Threpsi Care LLP at 7.27%, and individual investors at 5.91%. Mutual funds hold 11.61%, while foreign institutional investors account for 3.29%, with no pledged promoter holdings reported.

The top shareholders of Zydus Wellness include Zydus Lifesciences Limited, which holds the largest stake at 57.59%. Other significant shareholders are Threpsi Care LLP, with a holding of 7.27%, and individual investors, who collectively own 5.91%. Additionally, mutual funds are represented through 13 schemes, accounting for 11.61% of the shares, while foreign institutional investors (FIIs) hold 3.29% through 101 different entities. There are no pledged promoter holdings reported.

Has Zydus Wellness declared dividend?

Zydus Wellness Ltd has declared a 50% dividend, amounting to ₹5 per share, with an ex-date of July 19, 2024. The dividend yield is 0.26%, and total returns over the past five years stand at 51.68%.

Zydus Wellness Ltd has declared a 50% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 50%<BR>- Amount per share: 5<BR>- Ex-date: 19 Jul 24<BR><BR>Dividend Yield: 0.26%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -4.86%, the dividend return was 0%, resulting in a total return of -4.86%.<BR><BR>Over the past year, the price return was 3.51%, the dividend return was 0.26%, leading to a total return of 3.77%.<BR><BR>In the 2-year period, the price return was 28.84%, the dividend return was 0.67%, culminating in a total return of 29.51%.<BR><BR>For the 3-year period, the price return was 23.44%, the dividend return was 0.97%, resulting in a total return of 24.41%.<BR><BR>In the last 4 years, the price return was -7.19%, the dividend return was 0.96%, leading to a total return of -6.23%.<BR><BR>Over the past 5 years, the price return was 50.14%, the dividend return was 1.54%, resulting in a total return of 51.68%.<BR><BR>Overall, Zydus Wellness has declared a dividend, which contributes to a modest dividend yield. The total returns over various periods show a mix of positive and negative performance, with the 5-year period reflecting the strongest total return.